MoneyWorks4Me

Hind Bio Science - Quaterly Results

25 May 2024 Evaluate
The Revenue for the quarter ended  March 2024 of Rs. 3.89 millions grew by 16.82 % from Rs. 3.33 millions.The Net Profit of the company vaulted to 185.71% to Rs. 0.40  millions from Rs. 0.14 millions in the previous quarter.Operating profit surged to 0.44 millions from the corresponding previous quarter of 0.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3.89 3.33 16.82 10.29 9.22 11.61 10.29 9.22 11.61
Other Income -0.01 0.00 0.00 0.24 0.00 0.00 0.24 0.00 0.00
PBIDT 0.44 0.20 120.00 0.64 -0.28 -328.57 0.64 -0.28 -328.57
Interest 0.01 0.02 -50.00 0.04 0.04 0.00 0.04 0.04 0.00
PBDT 0.43 0.18 138.89 0.60 -0.32 -287.50 0.60 -0.32 -287.50
Depreciation 0.03 0.02 50.00 0.07 0.06 16.67 0.07 0.06 16.67
PBT 0.40 0.16 150.00 0.53 -0.38 -239.47 0.53 -0.38 -239.47
TAX 0.00 0.02 0.00 -0.04 0.02 -300.00 -0.04 0.02 -300.00
Deferred Tax 0.00 0.02 0.00 -0.04 0.02 -300.00 -0.04 0.02 -300.00
PAT 0.40 0.14 185.71 0.57 -0.40 -242.50 0.57 -0.40 -242.50
Equity 20.50 20.50 0.00 20.50 20.50 0.00 20.50 20.50 0.00
PBIDTM(%) 11.31 6.01 88.33 6.22 -3.04 -304.80 6.22 -3.04 -304.80
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..